The "Beam-Me-In Strategy" - remote haptic therapist-patient interaction with two exoskeletons for stroke therapy.
Kilian Baur, Nina Rohrbach, Joachim Hermsdörfer and 2 others
PMID 31296226WHAT IT FOUND
Fifteen therapists used two linked exoskeleton robots to feel simulated stroke impairments in their own arms.
They reliably distinguished healthy from severely affected movement patterns. This haptic feedback let them assess range of motion and muscle tone remotely, though accuracy varied by task.
Key findings
01Therapists correctly differentiated simulated active and passive range of motion in 93.3% of cases, with a mean absolute error of 4.9 degrees.
02Fourteen of fifteen participants identified the 'catch' angle in simulated severe spasticity, and inter-rater reliability for muscle tone scores was excellent.
03All therapists distinguished between healthy, mildly affected, and severely affected movement synergy patterns, but reliability for judging movement smoothness was only fair.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study used simulated or recorded movements, not live patients, so it does not prove the system works for real-time remote therapy. The sample size was very small (15 therapists), limiting generalizability. Therapists had varying levels of experience with robots, and most had little or no prior experience with the specific ARMin device. The simulated impairments were not validated against actual clinical populations, so the 'patient' data may not reflect real-world variability. Accuracy for judging movement smoothness was poor (fair reliability), indicating the system may not capture subtle movement quality differences well. Therapists reported only moderate agreement that the haptic experience allowed them to detect individual patient problems, suggesting the 'empathy' or clinical insight aspect is limited.
Declared interests
The study was supported by non-U.S. government funding. No specific commercial conflicts of interest were declared in the provided text, though the ARMin robot is a commercial research device.
The easy way to misread this
Do not assume this system is ready for clinical use. The therapists assessed simulated or pre-recorded movements, not live patients, and the reliability for judging movement smoothness was only fair. It is a feasibility test of haptic transmission, not a validated diagnostic tool.